Welcome to HPR LLP; where science meets impact. Our services accelerate medical progress, elevate patient well-being, and empower sponsors with trusted, transparent collaboration every step of the way.
We empower pharmaceutical teams with real-time analytics, unify clinical, real-world, and molecular data, and deliver actionable insights that de-risk trials, accelerate development, and optimize market strategies while upholding the highest standards of privacy and compliance.
Guided by our world-class Medical Advisory Board, we provide strategic medical guidance, pharmacovigilance leadership, and evidence-generation expertise across the product lifecycle from early research to post-market stewardship.
Our commitment to ethical leadership, rigorous data governance, and open, accountable collaboration positions hello as a trusted partner for patients, clinicians, regulators, and industry partners alike.
hello specializes in medical communications and real-world evidence (RWE) data services, delivering evidence-based insights that accelerate safe, patient-centered healthcare solutions. We transform complex biomedical data into clear, actionable guidance for pharmaceutical and device developers, clinicians, regulators, and payers.
Through comprehensive offerings in broad medical communications, CME strategy, content development, and dedicated RWE website portals, we empower teams with real-time analytics, standardized data standards (including CDISC and OMOP), and rigorous methodology.
Transforming complex scientific data into actionable insights for pharmaComplex data. Clear decisions.Real-time data. Real-world impact.Transforming data into decisive action.Intelligent analytics for smarter trials.At Hellocratic Pharma Research LLP (hello), our purpose is to advance global health through rigorous biomedical research, ethical innovation, and translational collaboration that places patient welfare at the heart of every endeavor. Our mission is to discover and develop safe, effective therapies that address unmet medical needs while upholding the highest standards of scientific integrity, transparency, and governance. By empowering pharmaceutical teams with real-time analytics, integrating diverse data domains: clinical, real-world, and molecular and de-risking trials, we accelerate evidence-based decision-making from bench to bedside. Through our Medico-Marketing integration, we translate complex scientific insights into strategic, evidence-focused communications that educate patients, clinicians, and stakeholders. Our Post-Marketing Surveillance (PMS) programs ensure ongoing safety and real-world effectiveness, with robust governance, ethical engagement of KOLs, and transparent data stewardship. Together, these capabilities enable us to deliver decisive action, enhance patient outcomes, and contribute to a healthier world through trusted partnerships, rigorous data governance, and a steadfast commitment to ethical practice.
Empower pharmaceutical teams with real-time analyticsIntegrate disparate data domains: clinical, real-world, molecularDe-risk trials, accelerate R&D, optimize market strategySecure, governed data pipelines that protect privacy and complianceProvide fast customer support and quick resolutions.Clinical trial data (EHR, imaging, biomarkers)Real-world data (claims, registries, PROs)Molecular/genomic data (omics pipelines, target validation)Data strategy, architecture, model development, deploymentSupport and training for teamsSecurity and compliance governance and auditsCardiology and Vascular MedicineOncology and HaematologyNeurology and NeurosciencesEndocrinology and Metabolic MedicineRespiratory and Critical Care MedicineInfectious Diseases and ImmunologyNephrology and UrologyGastroenterology and HepatologyRheumatology and Musculoskeletal MedicinePaediatrics and NeonatologyDermatology and VenereologyPsychiatry, Psychology, and Behavioral HealthOncology Supportive Care and Palliative MedicineGeriatrics and GerontologyGlobal Health and Public Health MedicinePharmacology, Pharmacovigilance, and Drug SafetyCell and Gene TherapiesDermatologyObesityOpthalmologyRare DiseasePulmonologyWomen’s HealthMedical DevicesOrphan/Rare Disease